RELATED CONTENT
NEWS
- Novo Nordisk's sales jump but still miss expectations
- Antidiabetic GLP-1s only linked to thyroid cancer in rodents, study suggests
- Novo Nordisk pushed for US liraglutide update as first-half sales leap
- No new trials needed in US FDA complete response letter for once-weekly exenatide
COMMENT
Other Informa Comment
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009


